10 results
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
protection authorities or data subjects, limitations on retention and secondary use of information, increased requirements pertaining to health data
F-1/A
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
to appropriate data protection authorities or data subjects, limitations on retention and secondary use of information, increased requirements pertaining
F-1/A
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
17 Mar 21
Registration statement (foreign) (amended)
6:38am
preceding sentence shall be limited to the number of Shares which have a Fair Market Value on the date of delivery or retention no greater than … under clause (ii) above by the Company’s retention of Shares from the Award creating the tax obligation and there is a public market for Shares
F-1/A
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
subjects, limitations on retention and secondary use of information, increased requirements pertaining to health data and pseudonymised (i.e., key
F-1/A
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
must follow any formal document retention policy of the Company with respect to Company records within such employee’s or director’s control. Please
F-1/A
EX-1.1
sm27eceyiwfrga9
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
6keog
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
du5x vjqi
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
41ub8y8hrpfdoc5p
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
r7iqvjw2y73m4e0j6zi
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next